Back to Search
Start Over
Desferrioxamine-caffeine (DFCAF) as a cell permeant moderator of the oxidative stress caused by iron overload.
- Source :
-
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine [Biometals] 2014 Dec; Vol. 27 (6), pp. 1351-60. Date of Electronic Publication: 2014 Sep 30. - Publication Year :
- 2014
-
Abstract
- Desferrioxamine (DFO) is a potent iron chelator used in the treatment of iron overload (IO) disorders. However, due to its low cell permeability and fast clearance, DFO administration is usually prolonged and of limited use for the treatment of IO in tissues such as the brain. Caffeine is a safe, rapidly absorbable molecule that can be linked to other compounds to improve their cell permeability. In this work, we successfully prepared and described DFO-caffeine, a conjugate with iron scavenging ability, antioxidant properties and enhanced permeation in the HeLa cell model.
- Subjects :
- Antioxidants administration & dosage
Antioxidants pharmacology
Caffeine administration & dosage
Cell Membrane Permeability
Deferoxamine administration & dosage
Drug Evaluation, Preclinical
Ferric Compounds metabolism
Ferric Compounds toxicity
Fluoresceins analysis
Fluorescent Dyes analysis
HeLa Cells
Humans
Iron Chelating Agents administration & dosage
Molecular Structure
Nitrilotriacetic Acid analogs & derivatives
Nitrilotriacetic Acid metabolism
Nitrilotriacetic Acid toxicity
Caffeine pharmacology
Deferoxamine pharmacology
Iron Chelating Agents pharmacology
Iron Overload drug therapy
Oxidative Stress drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1572-8773
- Volume :
- 27
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
- Publication Type :
- Academic Journal
- Accession number :
- 25265871
- Full Text :
- https://doi.org/10.1007/s10534-014-9795-7